A detailed history of Horizon Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 20,544 shares of ABBV stock, worth $3.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
20,544
Previous 11,825 73.73%
Holding current value
$3.6 Million
Previous $2.03 Million 100.05%
% of portfolio
0.09%
Previous 0.05%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $1.43 Million - $1.74 Million
8,719 Added 73.73%
20,544 $4.06 Million
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $2.15 Million - $2.51 Million
-13,905 Reduced 54.04%
11,825 $2.03 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $172,605 - $196,668
1,080 Added 4.38%
25,730 $4.69 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $1.1 Million - $1.23 Million
-7,964 Reduced 24.42%
24,650 $3.82 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $59,714 - $69,128
447 Added 1.39%
32,614 $4.86 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $296,954 - $369,540
-2,241 Reduced 6.51%
32,167 $4.33 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $938,229 - $1.08 Million
6,488 Added 23.24%
34,408 $5.48 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $2.52 Million - $3.02 Million
18,186 Added 186.83%
27,920 $4.47 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $6.24 Million - $7.15 Million
-46,476 Reduced 82.68%
9,734 $1.29 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $378,455 - $481,140
-2,750 Reduced 4.66%
56,210 $8.53 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $3.4 Million - $4.22 Million
25,760 Added 77.59%
58,960 $9.48 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $2.26 Million - $2.87 Million
21,082 Added 173.97%
33,200 $4.45 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $3.72 Million - $4.23 Million
-34,990 Reduced 74.28%
12,118 $1.29 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $1.2 Million - $1.34 Million
-11,424 Reduced 19.52%
47,108 $5.25 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $5.99 Million - $6.59 Million
58,532 New
58,532 $6.33 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $3.7 Million - $4.99 Million
-45,940 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $2.39 Million - $2.81 Million
-27,842 Reduced 37.74%
45,940 $3.97 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $1.77 Million - $2.37 Million
24,110 Added 48.54%
73,782 $7.16 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $1.97 Million - $2.98 Million
30,505 Added 159.15%
49,672 $3.73 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $903,644 - $1.13 Million
12,528 Added 188.7%
19,167 $1.7 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $40,181 - $48,309
638 Added 10.63%
6,639 $495,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $37,383 - $47,784
569 Added 10.47%
6,001 $436,000
Q1 2019

May 16, 2019

BUY
$77.14 - $90.79 $247,927 - $291,799
3,214 Added 144.91%
5,432 $432,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $172,671 - $212,950
2,218 New
2,218 $204,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.